Affordable medicine is a grand challenge of our time.
OSP3 will be a singular gathering of researchers, entrepreneurs, industry professionals, funders and NGOs and who want to achieve radical improvements in the way we deliver therapeutics to market in the 21st century.
Open source brings the promise of efficient, robust and inclusive routes to discovery. While great progress has been made in opening up the discovery and development of new medicines, there remain major barriers to open source medicines reaching patients. Our task in this meeting is to learn about and spark new initiatives, to understand the main challenges together and to propose new, realistic solutions for implementation.
OSP3 will be a singular gathering of researchers, entrepreneurs, industry professionals, funders and NGOs and who want to achieve radical improvements in the way we deliver therapeutics to market in the 21st century.
Open source brings the promise of efficient, robust and inclusive routes to discovery. While great progress has been made in opening up the discovery and development of new medicines, there remain major barriers to open source medicines reaching patients. Our task in this meeting is to learn about and spark new initiatives, to understand the main challenges together and to propose new, realistic solutions for implementation.
This meeting follows the 1st OSP conference, which took place at the Bellagio Center, Lake Como, Italy in 2014, and the second, which took place at Castle Rauischholzhausen, Marburg, Germany in 2015. Partners and sponsors have included The Rockefeller Foundation, Open Society Foundations and Tata Trusts.
|
Number of Attendees: 50 invited attendees, feeding significant “live” social media outreach
Partners and Sponsors: CRI-Paris, Cures Within Reach, Open Source Malaria, European & Developing Countries Clinical Trials Partnership, Tata Trusts, Philipps-University Marburg, Open Source Pharma Foundation, Sage Bionetworks, Mayo Clinic TB Center Committed Participants include:
|
Funding: The partners are now seeking additional sponsorship for the meeting to cover the transportation costs for selected participants lacking resources (25K Euros) and lodging for selected participants (25K Euros). Contributors will be acknowledged on the conference web page and throughout/following the meeting.
Venue: The newly renovated building of CRI, a global leader in open science and quantitative approaches to biology, situated in the heart of Paris. Organizing Contacts: Peter Kolb (University of Marburg, peter.kolb@uni-marburg.de) Matthew Todd (University of Sydney, matthew.todd@sydney.edu.au) Jaykumar Menon (McGill University, jaykumar.menon@mcgill.ca) Wengsi Chiu (Open Source Pharma, weng-si.chiu@mail.mcgill.ca) Ariel Lindner (CRI, ariel.lindner@inserm.fr) Previous Conferences:
|